PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 32162808-8 2020 Patients with tumor PD-L1 >= 1% had a significantly longer DFS in sequential chemotherapy than in than 5-FU/LV arm (interaction p = .04) and a trend for OS (interaction p = .12). Leucovorin 108-110 CD274 molecule Homo sapiens 20-25 32162808-12 2020 Moreover, tumor PD-L1 expression >=1% was associated with greater benefit from intensive sequential chemotherapy compared with 5-fluorouracil plus leucovorin (5-FU/LV), whereas PD-L1 expression <1% was not, conditioning a statistically significant interaction between such biomarker and treatment arms. Leucovorin 164-166 CD274 molecule Homo sapiens 16-21 31767795-8 2019 Patients with tumor PD-L1 >= 1% had a significantly longer DFS in sequential chemotherapy than in than 5-FU/LV arm (interaction p = .04) and a trend for OS (interaction p = .12). Leucovorin 108-110 CD274 molecule Homo sapiens 20-25 31767795-12 2019 Moreover, tumor PD-L1 expression >=1% was associated with greater benefit from intensive sequential chemotherapy compared with 5-fluorouracil plus leucovorin (5-FU/LV), whereas PD-L1 expression <1% was not, conditioning a statistically significant interaction between such biomarker and treatment arms. Leucovorin 164-166 CD274 molecule Homo sapiens 16-21